10/10/2024 | Press release | Distributed by Public on 10/10/2024 15:30
Item 5.07. Submission of Matters to a Vote of Security Holders.
The 2024 Annual Meeting of Shareholders of BioNexus Gene Lab Corp. (the "Company") was held on Friday, October 4, 2024 ("Annual Meeting"). The voting results on the five (5) proposals considered and voted on at the Annual Meeting, all of which were described in the Company's proxy statement filed with the Securities and Exchange Commission on September 16, 2024, were as follows:
Proposal 1. Re-election of Directors
The five (5) director nominees for election to the Company's Board of Directors were elected to serve until the 2025 annual meeting of shareholders. The voting results were as follows:
Director Name |
FOR |
AGAINST |
ABSTAIN |
UNCAST |
||||||||||||
Su-Leng Tan Lee |
4,128,618 | 6,346,661 | 1,928 | 7,490,456 | ||||||||||||
Koon Wai Wong |
10,458,424 | 17,107 | 1,257 | 7,490,456 | ||||||||||||
Wei Foong Lim |
9,649,633 | 321,295 | 505,860 | 7,490,456 | ||||||||||||
Muhammad Azrul bin Abdul Hamid |
4,119,842 | 6,355,920 | 1,217 | 7,490,456 | ||||||||||||
Chee Keong Yap |
4,124,636 | 6,350,995 | 1,157 | 7,490,456 |
Proposal 2. Re-appointment of Auditor
To re-appoint JP Centurion & Partners PLT in Kuala Lumpur, Malaysia, as auditor of the Company to hold office from the conclusion of the Annual Meeting until the conclusion of the annual meeting of the Company to be held in 2025, and to approve the discretion of the Board to determine the remuneration of the same. The proposal was approved. The voting results were as follows:
Voting Results |
FOR |
AGAINST |
ABSTAIN |
UNCAST |
||||||||||||
Votes Cast |
10,720,634 | 17,334 | 30 | 7,229,665 |
Proposal 3. Approval of the 2024 Stock Incentive Plan
The proposal was not approved (see Item 8.01 Other Matters below). The voting results were as follows:
Voting Results |
FOR |
AGAINST |
ABSTAIN |
UNCAST |
||||||||||||
Votes Cast |
4,094,117 | 6,382,176 | 495 | 7,490,875 |
2 |
Proposal 4. Approval of a Reverse Stock Split Proposal
Approval of an amendment to our Amended and Restated Certificate of Incorporation to effect a reverse stock split of our outstanding shares of common stock, no par value, at a ratio ranging from one-for-two (1:2) to one-for-ten (1:10), with the exact ratio to be set within that range at the discretion of our Board of Directors without further approval or authorization of our stockholders. The proposal was not approved (see Item 8.01 Other Matters below). The voting results were as follows:
Voting Results |
FOR |
AGAINST |
ABSTAIN |
UNCAST |
||||||||||||
Votes Cast |
4,371,573 | 6,378,201 | 1 | 7,217,888 |
Proposal 5. Approval of an Adjournment of the Annual Meeting
Approval of an adjournment of the Annual Meeting if necessary to solicit additional proxies if there are not sufficient votes in favor of Proposal No. 1 (the "Adjournment Proposal"). The proposal was not approved. The voting results were as follows:
Voting Results |
FOR |
AGAINST |
ABSTAIN |
UNCAST |
||||||||||||
Votes Cast |
4,387,017 | 6,362,466 | 292 | 7,217,888 |